Bruker Gross Margin 2012-2026 | BRKR
Current and historical gross margin for Bruker (BRKR) over the last 10 years. The current gross profit margin for Bruker as of March 31, 2026 is %.
| Bruker Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-03-31 | $3.46B | $1.57B | 45.29% |
| 2025-12-31 | $3.44B | $1.58B | 45.90% |
| 2025-09-30 | $3.44B | $1.62B | 47.14% |
| 2025-06-30 | $3.44B | $1.66B | 48.26% |
| 2025-03-31 | $3.45B | $1.69B | 48.98% |
| 2024-12-31 | $3.37B | $1.65B | 49.01% |
| 2024-09-30 | $3.24B | $1.59B | 48.97% |
| 2024-06-30 | $3.12B | $1.55B | 49.71% |
| 2024-03-31 | $3.00B | $1.51B | 50.22% |
| 2023-12-31 | $2.96B | $1.51B | 51.08% |
| 2023-09-30 | $2.82B | $1.45B | 51.45% |
| 2023-06-30 | $2.71B | $1.40B | 51.66% |
| 2023-03-31 | $2.62B | $1.36B | 51.87% |
| 2022-12-31 | $2.53B | $1.31B | 51.58% |
| 2022-09-30 | $2.51B | $1.28B | 51.14% |
| 2022-06-30 | $2.48B | $1.26B | 50.71% |
| 2022-03-31 | $2.46B | $1.24B | 50.37% |
| 2021-12-31 | $2.42B | $1.21B | 50.08% |
| 2021-09-30 | $2.36B | $1.18B | 50.02% |
| 2021-06-30 | $2.27B | $1.12B | 49.49% |
| 2021-03-31 | $2.12B | $1.03B | 48.42% |
| 2020-12-31 | $1.99B | $0.94B | 47.23% |
| 2020-09-30 | $1.96B | $0.92B | 47.04% |
| 2020-06-30 | $1.97B | $0.93B | 47.11% |
| 2020-03-31 | $2.04B | $0.97B | 47.76% |
| 2019-12-31 | $2.07B | $1.00B | 48.02% |
| 2019-09-30 | $2.03B | $0.97B | 47.98% |
| 2019-06-30 | $1.97B | $0.94B | 47.72% |
| 2019-03-31 | $1.93B | $0.92B | 47.56% |
| 2018-12-31 | $1.90B | $0.90B | 47.44% |
| 2018-09-30 | $1.87B | $0.88B | 47.12% |
| 2018-06-30 | $1.84B | $0.86B | 46.61% |
| 2018-03-31 | $1.81B | $0.84B | 46.25% |
| 2017-12-31 | $1.77B | $0.82B | 46.18% |
| 2017-09-30 | $1.71B | $0.78B | 45.90% |
| 2017-06-30 | $1.66B | $0.77B | 46.21% |
| 2017-03-31 | $1.62B | $0.75B | 46.51% |
| 2016-12-31 | $1.61B | $0.75B | 46.24% |
| 2016-09-30 | $1.62B | $0.73B | 45.34% |
| 2016-06-30 | $1.62B | $0.72B | 44.23% |
| 2016-03-31 | $1.65B | $0.72B | 43.53% |
| 2015-12-31 | $1.62B | $0.71B | 43.66% |
| 2015-09-30 | $1.65B | $0.71B | 43.11% |
| 2015-06-30 | $1.68B | $0.71B | 42.43% |
| 2015-03-31 | $1.74B | $0.74B | 42.78% |
| 2014-12-31 | $1.81B | $0.76B | 42.23% |
| 2014-09-30 | $1.85B | $0.78B | 42.31% |
| 2014-06-30 | $1.87B | $0.81B | 43.27% |
| 2014-03-31 | $1.87B | $0.81B | 43.37% |
| 2013-12-31 | $1.84B | $0.81B | 43.83% |
| 2013-09-30 | $1.80B | $0.81B | 44.96% |
| 2013-06-30 | $1.81B | $0.83B | 45.67% |
| 2013-03-31 | $1.78B | $0.81B | 45.76% |
| 2012-12-31 | $1.79B | $0.83B | 46.26% |
| 2012-09-30 | $1.75B | $0.81B | 46.06% |
| 2012-06-30 | $1.72B | $0.79B | 45.64% |
| 2012-03-31 | $1.70B | $0.78B | 45.94% |
| 2011-12-31 | $1.65B | $0.75B | 45.61% |
| 2011-09-30 | $1.59B | $0.73B | 45.92% |
| 2011-06-30 | $1.48B | $0.69B | 46.43% |
| 2011-03-31 | $1.38B | $0.64B | 46.24% |
| 2010-12-31 | $1.31B | $0.60B | 46.28% |
| 2010-09-30 | $1.26B | $0.59B | 47.17% |
| 2010-06-30 | $1.21B | $0.56B | 46.61% |
| 2010-03-31 | $1.16B | $0.54B | 46.47% |
| 2009-12-31 | $1.12B | $0.52B | 46.37% |
| 2009-09-30 | $1.06B | $0.48B | 45.39% |
| 2009-06-30 | $1.04B | $0.48B | 45.63% |
| 2009-03-31 | $1.10B | $0.49B | 44.91% |
| 2008-12-31 | $1.11B | $0.51B | 45.62% |
| 2008-09-30 | $1.14B | $0.53B | 46.17% |
| 2008-06-30 | $1.14B | $0.53B | 46.17% |
| 2008-03-31 | $1.06B | $0.50B | 46.57% |
| 2007-12-31 | $1.03B | $0.48B | 46.08% |
| 2007-09-30 | $1.24B | $0.57B | 46.00% |
| 2007-06-30 | $1.10B | $0.51B | 45.83% |
| 2007-03-31 | $0.96B | $0.45B | 46.78% |
| 2006-12-31 | $0.85B | $0.40B | 47.00% |
| 2006-09-30 | $0.44B | $0.20B | 45.68% |
| 2006-06-30 | $0.42B | $0.19B | 46.08% |
| 2006-03-31 | $0.39B | $0.18B | 45.66% |
| 2005-12-31 | $0.37B | $0.17B | 44.62% |
| 2005-09-30 | $0.39B | $0.17B | 43.85% |
| 2005-06-30 | $0.37B | $0.16B | 43.51% |
| 2005-03-31 | $0.36B | $0.15B | 42.42% |
| 2004-12-31 | $0.36B | $0.15B | 42.42% |
| 2004-09-30 | $0.27B | $0.11B | 38.60% |
| 2004-06-30 | $0.27B | $0.10B | 38.66% |
| 2004-03-31 | $0.27B | $0.11B | 39.85% |
| 2003-12-31 | $0.26B | $0.11B | 41.00% |
| 2003-09-30 | $0.30B | $0.12B | 41.75% |
| 2003-06-30 | $0.29B | $0.12B | 41.92% |
| 2003-03-31 | $0.26B | $0.11B | 42.64% |
| 2002-12-31 | $0.22B | $0.10B | 42.99% |
| 2002-09-30 | $0.22B | $0.10B | 45.41% |
| 2002-06-30 | $0.19B | $0.09B | 46.49% |
| 2002-03-31 | $0.18B | $0.08B | 46.93% |
| 2001-12-31 | $0.18B | $0.08B | 46.29% |
| 2001-09-30 | $0.09B | $0.05B | 53.33% |
| 2001-06-30 | $0.09B | $0.05B | 51.69% |
| 2001-03-31 | $0.09B | $0.04B | 51.76% |
| 2000-12-31 | $0.08B | $0.04B | 52.56% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $5.722B | $3.437B |
| Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |
| Harvard Bioscience (HBIO) | United States | $0.019B | 0.00 |